6533b7d9fe1ef96bd126c2e8

RESEARCH PRODUCT

The Influence of Microbiome Dysbiosis and Bacterial Biofilms on Epidermal Barrier Function in Atopic Dermatitis—An Update

Lidia RudnickaAnna Waśkiel-burnatLeszek BlicharzMohamad GoldustZbigniew SamochockiMalgorzata OlszewskaJoanna Czuwara

subject

ExacerbationQH301-705.5microbiomeReviewmedicine.disease_causeCatalysisDermatitis AtopicInorganic ChemistryAnimalsHumansMedicineskin barrierMicrobiomeBiology (General)Physical and Theoretical ChemistryQD1-999Molecular BiologySpectroscopySkinstaphylococciEpidermal barrierBacteriaatopic dermatitisintegumentary systembusiness.industryMicrobiotaOrganic ChemistryBiofilmGeneral MedicineAtopic dermatitisImmune dysregulationmedicine.diseaseComputer Science ApplicationsChemistryImmunologyDysbiosisEpidermisbiofilmsbusinessDysbiosisFunction (biology)

description

Atopic dermatitis (AD) is a common inflammatory dermatosis affecting up to 30% of children and 10% of adults worldwide. AD is primarily driven by an epidermal barrier defect which triggers immune dysregulation within the skin. According to recent research such phenomena are closely related to the microbial dysbiosis of the skin. There is growing evidence that cutaneous microbiota and bacterial biofilms negatively affect skin barrier function, contributing to the onset and exacerbation of AD. This review summarizes the latest data on the mechanisms leading to microbiome dysbiosis and biofilm formation in AD, and the influence of these phenomena on skin barrier function.

https://doi.org/10.3390/ijms22168403